Bin Zheng
Director/Board Member chez Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Profil
Bin Zheng is an Independent Director who currently holds a position at Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
He previously held the same position at Nations Technologies, Inc., ENC Digital Technology Co. Ltd., and Tibet Aim Pharm., Inc.
Postes actifs de Bin Zheng
| Sociétés | Poste | Début |
|---|---|---|
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
 Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Sihuan Kebao Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical preparations. Its products include nicorandil for injection, terbutaline sulfate for injection, troxerutin for injection, aminomethylbenzoic acid for injection, isosorbide dinitrate for injection, and olopatadine hydrochloride tablets. The company was founded on December 4, 1998 and is headquartered in Beijing, China. | Director/Board Member | 01/12/2021 |
Anciens postes connus de Bin Zheng
| Sociétés | Poste | Fin |
|---|---|---|
| TIBET AIM PHARM. INC. | Director/Board Member | - |
| ENC DIGITAL TECHNOLOGY CO., LTD | Director/Board Member | - |
| NATIONS TECHNOLOGIES INC. | Director/Board Member | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| NATIONS TECHNOLOGIES INC. | Electronic Technology |
| TIBET AIM PHARM. INC. | Health Technology |
| ENC DIGITAL TECHNOLOGY CO., LTD | Technology Services |
| Entreprise privées | 1 |
|---|---|
Beijing Sihuan Kebao Pharmaceutical Co., Ltd.
Beijing Sihuan Kebao Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Beijing Sihuan Kebao Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical preparations. Its products include nicorandil for injection, terbutaline sulfate for injection, troxerutin for injection, aminomethylbenzoic acid for injection, isosorbide dinitrate for injection, and olopatadine hydrochloride tablets. The company was founded on December 4, 1998 and is headquartered in Beijing, China. | Health Technology |
